DocSym
β
Searchsearch
Search
(B46.3) Cutaneous mucormycosis
More details coming soon
1 727 in individuals diagnosis cutaneous mucormycosis confirmed
2 784 deaths with diagnosis cutaneous mucormycosis
161% mortality rate associated with the disease cutaneous mucormycosis
Diagnosis cutaneous mucormycosis is diagnosed Men are 28.20% more likely than Women
1 107
Men receive the diagnosis cutaneous mucormycosis
2 068 (186.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
620
Women receive the diagnosis cutaneous mucormycosis
716 (115.5 %)Died from this diagnosis.
Risk Group for the Disease cutaneous mucormycosis - Men aged 15-19 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 35-39, 50-59
Less common in men the disease occurs at Age 0-14, 20-34, 40-49, 60-95+Less common in women the disease occurs at Age 0-64, 70-95+
In Women diagnosis is most often set at age 65-69
Disease Features cutaneous mucormycosis
Absence or low individual and public risk
Cutaneous mucormycosis - what does this mean
Cutaneous mucormycosis is a rare fungal infection that occurs when the spores of the fungus enter the skin through a break, such as a cut, scrape, burn, or insect bite. the fungus can then spread to the underlying tissue, resulting in necrosis and ulceration of the skin.
What happens during the disease - cutaneous mucormycosis
Cutaneous mucormycosis is a rare but serious fungal infection caused by a group of molds called mucormycetes. it is most commonly caused by direct contact with soil or decaying vegetation contaminated with the fungus, inhalation of spores, or through a wound in the skin. it can cause tissue necrosis and spread to other parts of the body, and can be fatal if not treated quickly and appropriately.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Clinical Assessment
- Physical Examination
- Laboratory Tests
- Imaging Tests
- Skin Biopsy
- Pulmonary Function Tests
- Blood Tests
- Urine Tests
- Molecular Diagnostics
Treatment and Medical Assistance
Main goal of the Treatment: To reduce the spread of infection and improve the patient's overall health.
- Prescribing antifungal medications
- Administering intravenous antifungal medications
- Surgical removal of infected tissue
- Debridement of the infected area
- Administering antifungal creams or ointments
- Administering antibiotics to treat any underlying infections
- Providing wound care
- Providing supportive care, such as pain relief and nutrition
38 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cutaneous mucormycosis - Prevention
Cutaneous mucormycosis can be prevented by avoiding contact with infected individuals, wearing protective gear when in contact with soil or compost, maintaining good hygiene, and avoiding contact with contaminated materials such as garden tools and soil. it is also important to keep cuts and wounds clean and covered, and to avoid sharing personal items such as towels or razors.